研究成果
年分
作者
期刊
研究名稱
2021
Wang WT, Wu TC, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Leu HB, Yin WH, Wu CC, Chen JW*.
Medicine (Baltimore). 2021; 100(48) (IF: 1.889)
Prognostic indicators for the onset of ischaemic versus haemorrhagic stroke in stable coronary artery disease.
2021
Wilde AAM*, Wu CI.
Eur. Heart J. 2021; 42(29): 2864. (IF: 29.983)
Does function trump bioinformatics in Brugada syndrome-associated SCN5A mutation calling? Patients, computers, and patches.
2021
Yang YL, Chen SC, Wu CH, Huang SS, Chan WL, Lin SJ, Chou CY, Chen JW, Pan JP, Charng MJ, Chen YH, Wu TC, Lu TM, Hsu PF, Huang PH, Cheng HM, Huang CC, Sung SH, Lin YJ, Leu HB*.
J. Clin. Hypertens. 2021; 23(8): 1622-1630. (IF: 3.738)
Optimal blood pressure for patients with end-stage renal disease following coronary interventions.
2021
Yang YL, Leu HB*, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Chen JW.
J. Chin. Med. Assoc. 2021; 84(6) :596-605. (IF: 2.743)
Adherence to healthy lifestyle improved clinical outcomes in coronary artery disease patients after coronary intervention.
2021
Yingchoncharoen T, Wu TC, Choi DJ, Ong TK, Liew HB, Cho MC*.
Korean Circ. J. 2021; 51(8):681-693. (IF: 3.243)
Economic Burden of Heart Failure in Asian Countries with Different Healthcare Systems.
2021
Yen CH, Lin JL, Sung KT, Su CH, Huang WH, Chen YY, Chien SC, Lai YH, Lee PY, Liu YY, Tsai JP, Tsai CT, Hou CJY, Chen YJ, Hsieh YJ, Hung CL*, Hung TC, Yeh HI
Sci Rep. 2021; 11(1):16501. (IF: 4.380)
Association of free fatty acid binding protein with central aortic stiffness, myocardial dysfunction and preserved ejection fraction heart failure.
2021
Yugo D, Chen YC, Lin YK, Liu CM, Huang JH, Chen SA, Chen YJ*.
Eur. J. Clin. Invest. 2021; 51(9):e13585. (IF: 4.686)
Effects of phosphodiesterase-1 inhibitor on pulmonary vein electrophysiology and arrhythmogenesis.
2021
Wang JG*, Li Y, Chia YC, Cheng HM, Minh HV, Siddique S, Sogunuru GP, Tay JC, Teo BW, Tsoi K, Turana Y, Wang TD, Zhang YQ, Kario K.
J. Clin. Hypertens. 2021; 23(3) : 435-439. (IF: 3.738)
Telemedicine in the management of hypertension: Evolving technological platforms for blood pressure telemonitoring.
2021
Wang CY, Liu SY, Kuo FH, Lin HF, Liu CY, Yang YP, Tsai FT, Huang WC, Tarng YW, Lin HC, Lu KH, Yu WC, Yang MY*.
J. Chin. Med. Assoc. 2021; 84(1) : 68-72. (IF: 2.743)
Using multiple-steps bioinformatic analysis to predict the potential microRNA targets by cardiogenic HoxA11.
2021
Tsai MH, Chiu YT, Chan DZH, Wen CH, Syu SH, Lu HE, Huang CYF, Lin YJ, Chang SL, Lo LW, Huang CY, Hu YF*, Hsieh PCH*, Chen SA.
Stem Cell Res. 2021; 54:102416. (IF:2.020)
Generation of IBMS-iPSC-021,-022,-023 human induced pluripotent stem cells (IBMSi016-A, IBMSi017-A, and IBMSi018-A) derived from patients with the ALDH2 rs671 polymorphism.